{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:26:50Z","timestamp":1784975210240,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Res Health Serv Reg"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Research on the epidemiology of autoimmune diseases is impeded due to the rarity of most autoimmune diseases. We aimed to assess the prevalence of diagnosed autoimmune diseases in Germany and examine their sex-specific and regional differences.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A cross-sectional study using the nationwide ambulatory claims data of females and males of any age with statutory health insurance from 2022 was designed (<jats:italic>N<\/jats:italic>\u2009=\u200973,241,305). Autoimmune diseases were identified by diagnostic codes of the International Classification of Diseases and Related Health Problems, 10th Revision, German Modification (ICD-10-GM). Regional differences were examined at the level of urban and rural districts (<jats:italic>N<\/jats:italic>\u2009=\u2009401). To control for demographic differences across districts we applied the direct standardization method to calculate sex- and age-standardized prevalences with the German population in 2022 used as a standard population. Furthermore, we calculated prevalence ratios (PR) and 99% confidence intervals (99% CI) to examine sex differences.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 73,241,305 insurees (median age, 45; interquartile range, 26\u201363\u00a0years), 6,307,120 had at least one (any) autoimmune disease in 2022, corresponding to a crude prevalence of 8.61% (99% CI: 8.60\u20138.62%). Of all individuals with autoimmune diseases, 67% were females. The prevalence of single autoimmune diseases varied between 0.008% (pemphigus) and 2.3% (autoimmune thyroiditis). Other autoimmune diseases with a high prevalence were psoriasis (1.9%), rheumatoid arthritis (1.4%), and type 1 diabetes (0.75%). The prevalence was higher in females than males for 25 of the 31 autoimmune diseases with the highest PR observed for autoimmune thyroiditis (PR 5.92; 99% CI: 5.88\u20135.95), primary biliary cirrhosis (5.60; 5.36\u20135.84) and systemic lupus erythematosus (5.15; 4.97\u20135.36). Males were more likely to be diagnosed than females with type 1 diabetes (1.37; 1.36\u20131.39), ankylosing spondylitis (1.40; 1.39\u20131.43) and Guillain-Barr\u00e9 syndrome (1.31; 1.27\u20131.37). The only autoimmune disease without sex difference was myasthenia gravis (1.00; 0.97\u20131.03). At district level the age- and sex-standardized prevalence of at least one (any) autoimmune disease differed by a factor of nearly 2 between 5.91% and 11.62%. In general, the prevalence was higher in East (former GDR) than West (former FRG) Germany.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Although most autoimmune diseases were rare, when considered as a whole, autoimmune diseases turned out to be more common than previously assumed, with one out of 12 individuals affected in Germany.\n<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s43999-025-00061-5","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T01:00:24Z","timestamp":1743210024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sex-specific and regional differences in the prevalence of diagnosed autoimmune diseases in Germany, 2022"],"prefix":"10.1007","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2310-3179","authenticated-orcid":false,"given":"Manas K.","family":"Akmatov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1865-1923","authenticated-orcid":false,"given":"Claudia","family":"Kohring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3434-2311","authenticated-orcid":false,"given":"Frank","family":"Pessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Holstiege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"61_CR1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/a-1192-4628","volume":"83","author":"C Kienitz","year":"2021","unstructured":"Kienitz C, Grellmann C, Hapfelmeier J (2021) [Prevalence of rheumatoid arthritis in Germany: analysis of longitudinal data of statutory health insurance]. Gesundheitswesen 83:367\u2013373","journal-title":"Gesundheitswesen"},{"key":"61_CR2","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103534","volume":"59","author":"J Holstiege","year":"2022","unstructured":"Holstiege J, Akmatov MK, Klimke K, Dammertz L, Kohring C, Marx C et al (2022) Trends in administrative prevalence of multiple sclerosis and utilization patterns of disease modifying drugs in Germany. Mult Scler Relat Disord 59:103534","journal-title":"Mult Scler Relat Disord"},{"key":"61_CR3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40744-021-00277-0","volume":"8","author":"A Schwarting","year":"2021","unstructured":"Schwarting A, Friedel H, Garal-Pantaler E, Pignot M, Wang X, Nab H et al (2021) The burden of systemic lupus erythematosus in Germany: incidence, prevalence, and healthcare resource utilization. Rheumatol Ther 8:375\u2013393","journal-title":"Rheumatol Ther"},{"key":"61_CR4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/a-1135-9306","volume":"58","author":"M Sebode","year":"2020","unstructured":"Sebode M, Kloppenburg A, Aigner A, Lohse AW, Schramm C, Linder R (2020) Population-based study of autoimmune hepatitis and primary biliary cholangitis in Germany: rising prevalences based on ICD codes, yet deficits in medical treatment. Z Gastroenterol 58:431\u2013438","journal-title":"Z Gastroenterol"},{"key":"61_CR5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00393-022-01302-5","volume":"83","author":"K Albrecht","year":"2024","unstructured":"Albrecht K, Binder S, Minden K, Poddubnyy D, Regierer AC, Strangfeld A et al (2024) Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany. Z Rheumatol 83:20\u201330","journal-title":"Z Rheumatol"},{"key":"61_CR6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12026-009-8153-2","volume":"47","author":"WW Eaton","year":"2010","unstructured":"Eaton WW, Pedersen MG, Atladottir HO, Gregory PE, Rose NR, Mortensen PB (2010) The prevalence of 30 ICD-10 autoimmune diseases in Denmark. Immunol Res 47:228\u2013231","journal-title":"Immunol Res"},{"key":"61_CR7","unstructured":"Population data by sex and age. Federal Statistical Office, Wiesbaden. Available from: https:\/\/www-genesis.destatis.de\/genesis\/online. Cited 2024 May 01"},{"key":"61_CR8","unstructured":"R: A language and environment for statistical computing. Version 4.3.1. Vienna: R Foundation for Statistical Computing. Available from: https:\/\/www.R-project.org. Cited 2024 Apr. 01"},{"key":"61_CR9","doi-asserted-by":"crossref","first-page":"J168","DOI":"10.1016\/j.jaut.2009.11.018","volume":"34","author":"Y Shapira","year":"2010","unstructured":"Shapira Y, Agmon-Levin N, Shoenfeld Y (2010) Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 34:J168\u2013J177","journal-title":"J Autoimmun"},{"key":"61_CR10","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","volume":"401","author":"N Conrad","year":"2023","unstructured":"Conrad N, Misra S, Verbakel JY, Verbeke G, Molenberghs G, Taylor PN et al (2023) Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet 401:1878\u20131890","journal-title":"Lancet"},{"key":"61_CR11","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/annrheumdis-2023-eular.478","volume":"82","author":"T Alexander","year":"2023","unstructured":"Alexander T, Schulte M, Borchert J, Garcia T, Schrom E (2023) Incidence, prevalence and current treatment practice of systemic lupus erythematosus: a German claims data analysis. Ann Rheum Dis 82:1450\u20131451","journal-title":"Ann Rheum Dis"},{"key":"61_CR12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nmd.2023.02.002","volume":"33","author":"A Mevius","year":"2023","unstructured":"Mevius A, Jores L, Biskup J, Heidbrede T, Mahic M, Wilke T et al (2023) Epidemiology and treatment of myasthenia gravis: a retrospective study using a large insurance claims dataset in Germany. Neuromuscul Disord 33:324\u2013333","journal-title":"Neuromuscul Disord"},{"key":"61_CR13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000529583","volume":"57","author":"H Wartmann","year":"2023","unstructured":"Wartmann H, Hoffmann S, Ruck T, Nelke C, Deiters B, Volmer T (2023) Incidence, prevalence, hospitalization rates, and treatment patterns in myasthenia gravis: a 10-year real-world data analysis of German claims data. Neuroepidemiology 57:121\u2013128","journal-title":"Neuroepidemiology"},{"key":"61_CR14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00393-016-0088-0","volume":"75","author":"S Hense","year":"2016","unstructured":"Hense S, Luque RA, Callhoff J, Albrecht K, Zink A, Hoffmann F (2016) [Prevalence of rheumatoid arthritis in Germany based on health insurance data: regional differences and first results of the PROCLAIR study]. Z Rheumatol 75:819\u2013827","journal-title":"Z Rheumatol"},{"key":"61_CR15","doi-asserted-by":"crossref","unstructured":"Schmidt CO, Gunther KP, Goronzy J, Albrecht K, Chenot JF, Callhoff J, et al. [Frequencies of musculoskeletal symptoms and disorders in the population-based German National Cohort (GNC)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2020;63:415\u201325.","DOI":"10.1007\/s00103-020-03110-1"},{"key":"61_CR16","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00296-018-4124-z","volume":"38","author":"K Kruger","year":"2018","unstructured":"Kruger K, von Hinuber U, Meier F, Tian H, Bohm K, Jugl SM et al (2018) Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis. Rheumatol Int 38:2121\u201331","journal-title":"Rheumatol Int"},{"key":"61_CR17","first-page":"78","volume":"38 Suppl 126","author":"K Albrecht","year":"2020","unstructured":"Albrecht K, Dorner T, Redeker I, Karberg K, Marschall U, Zink A et al (2020) Comorbidity and health care utilisation in persons with Sjogren\u2019s syndrome: a claims data analysis. Clin Exp Rheumatol 38 Suppl 126:78\u201384","journal-title":"Clin Exp Rheumatol"},{"key":"61_CR18","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1111\/jdv.16467","volume":"34","author":"F Hubner","year":"2020","unstructured":"Hubner F, Konig IR, Holtsche MM, Zillikens D, Linder R, Schmidt E (2020) Prevalence and age distribution of pemphigus and pemphigoid diseases among paediatric patients in Germany. J Eur Acad Dermatol Venereol 34:2600\u20132605","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"61_CR19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00296-023-05446-8","volume":"44","author":"LI Sakkas","year":"2024","unstructured":"Sakkas LI, Chikanza IC (2024) Sex bias in immune response: it is time to include the sex variable in studies of autoimmune rheumatic diseases. Rheumatol Int 44:203\u2013209","journal-title":"Rheumatol Int"},{"key":"61_CR20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cell.2023.12.037","volume":"187","author":"DR Dou","year":"2024","unstructured":"Dou DR, Zhao Y, Belk JA, Zhao Y, Casey KM, Chen DC et al (2024) Xist ribonucleoproteins promote female sex-biased autoimmunity. Cell 187:733\u2013749","journal-title":"Cell"},{"key":"61_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/BOR.0000000000000564","volume":"31","author":"AC Billi","year":"2019","unstructured":"Billi AC, Kahlenberg JM, Gudjonsson JE (2019) Sex bias in autoimmunity. Curr Opin Rheumatol 31:53\u201361","journal-title":"Curr Opin Rheumatol"},{"key":"61_CR22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.clim.2013.03.003","volume":"149","author":"SK Tedeschi","year":"2013","unstructured":"Tedeschi SK, Bermas B, Costenbader KH (2013) Sexual disparities in the incidence and course of SLE and RA. Clin Immunol 149:211\u2013218","journal-title":"Clin Immunol"},{"key":"61_CR23","first-page":"827","volume":"105","author":"H Hauner","year":"2008","unstructured":"Hauner H, Bramlage P, Losch C, Jockel KH, Moebus S, Schunkert H et al (2008) Overweight, obesity and high waist circumference: regional differences in prevalence in primary medical care. Dtsch Arztebl Int 105:827\u2013833","journal-title":"Dtsch Arztebl Int"},{"key":"61_CR24","doi-asserted-by":"crossref","first-page":"e064249","DOI":"10.1136\/bmjopen-2022-064249","volume":"12","author":"P Grigoriev","year":"2022","unstructured":"Grigoriev P, Klusener S, van Raalte A (2022) Quantifying the contribution of smoking to regional mortality disparities in Germany: a cross-sectional study. BMJ Open 12:e064249","journal-title":"BMJ Open"},{"key":"61_CR25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.puhe.2024.09.010","volume":"236","author":"B Aretz","year":"2024","unstructured":"Aretz B, Frey S, Weltermann B (2024) Regional socioeconomic characteristics and density of general practitioners in Germany: a nationwide cross-sectional and longitudinal spatial analysis. Public Health 236:338\u2013346","journal-title":"Public Health"},{"key":"61_CR26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00103-010-1119-7","volume":"53","author":"J Huber","year":"2010","unstructured":"Huber J, Mielck A (2010) Morbidity and health care among statutory and privately insured individuals. Bundesgesundheitsbl 53:925\u2013938","journal-title":"Bundesgesundheitsbl"},{"key":"61_CR27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1055\/s-0031-1301268","volume":"74","author":"J Huber","year":"2012","unstructured":"Huber J, Lampert T (2012) Mielck A [Inequalities in health risks, morbidity and health care of children by health insurance of their parents (statutory vs. private health insurance): results of the German KiGGS study]. Gesundheitswesen 74:627\u2013638","journal-title":"Gesundheitswesen"}],"container-title":["Research in Health Services &amp; Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43999-025-00061-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43999-025-00061-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43999-025-00061-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T01:01:32Z","timestamp":1743210092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43999-025-00061-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["61"],"URL":"https:\/\/doi.org\/10.1007\/s43999-025-00061-5","relation":{},"ISSN":["2730-9827"],"issn-type":[{"value":"2730-9827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of claims data for scientific research is regulated by the Social Security Code (Sozialgesetzbuch V) in Germany. Ethical approval and informed consent are not required as this study used routinely collected anonymised data. The research was conducted in accordance with the Helsinki Declaration (in its current revised form: 64th WMA General Assembly, Fortaleza, Brazil, October 2013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}